首页|阿昔洛韦联合人免疫球蛋白静注治疗病毒性脑炎的效果分析

阿昔洛韦联合人免疫球蛋白静注治疗病毒性脑炎的效果分析

扫码查看
目的 分析阿昔洛韦联合人免疫球蛋白病毒性脑炎患儿的治疗效果.方法 单纯随机选取2022年6月—2023年6月泉州市第一医院儿科收治的90例病毒性脑炎患儿作为研究对象,按照随机数表法分为两组,各45例,对照组应用阿昔洛韦干预,观察组应用阿昔洛韦联合人免疫球蛋白干预,对比两组各项指标的恢复情况、炎性因子的水平和临床效果、治疗有效率、不良反应发生率.结果 观察组患儿症状恢复时间短于对照组,差异有统计学意义(P<0.05).治疗前两组血清炎症因子、脑脊液炎症因子比较,差异无统计学意义(P均>0.05);治疗后观察组血清炎症因子、脑脊液炎症因子优于对照组,差异有统计学意义(P均<0.05).观察组不良反应发生率为2.22%,低于对照组的13.33%,差异有统计学意义(x2=3.873,P<0.05).观察组治疗总有效率为97.78%,高于对照组的86.67%,差异有统计学意义(x2=3.873,P<0.05).结论 对病毒性脑炎的患儿应用阿昔洛韦联合人免疫球蛋白静注治疗有利于促进患儿的康复,减轻患儿的炎症反应,控制病情,修复神经,降低并发症发生率,促进病情转归.
Effect Analysis of Acyclovir Combined with Human Immunoglobulin in Treatment of Viral Encephalitis
Objective To analyze the therapeutic effect of acyclovir combined with human immunoglobulin virus en-cephalitis in children.Methods A total of 90 children with viral encephalitis admitted to the Department of Pediatrics of Quanzhou First Hospital from June 2022 to June 2023 were randomly selected as the study objects.They were di-vided into two groups with 45 cases in each group by random number table method.The control group was treated with acyclovir intervention,and the observation group was treated with acyclovir combined with human immunoglobulin in-tervention.The recovery of various indexes,the level of inflammatory factors and clinical effects,the treatment effec-tiveness,the incidence of adverse reactions of the two groups were compared.Results The recovery time of symptoms in observation group was shorter than that in control group,and the difference was statistically significant(P<0.05).There was no significant difference in serum inflammatory factors and cerebrospinal fluid inflammatory factors be-tween the two groups before treatment(both P>0.05).After treatment,the serum inflammatory factors and cerebrospi-nal fluid inflammatory factors in the observation group were better than those in the control group,and the differences were statistically significant(both P<0.05).The incidence of adverse reactions in the observation group was 2.22%,lower than that in the control group(13.33%),and the difference was statistically significant(x2=3.873,P<0.05).The total effective rate of the observation group was 97.78%,higher than that of the control group(86.67%),and the differ-ence was statistically significant(x2=3.873,P<0.05).Conclusion The application of acyclovir combined with human immunoglobulin in the treatment of viral encephalitis in children is beneficial to promote the recovery of children,re-duce the inflammatory response of children,control the disease,repair the nerve,reduce the incidence of complica-tions,and promote the prognosis of the disease.

AcyclovirIntravenous infusion of human immunoglobulinViral encephalitis

陈婷婷、许白叶

展开 >

泉州市第一医院儿科,福建泉州 362000

阿昔洛韦 人免疫球蛋白静注 病毒性脑炎

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(12)